NEURONES (NRO.PA) Fundamental Analysis & Valuation
EPA:NRO • FR0004050250
Current stock price
34.65 EUR
+1 (+2.97%)
Last:
This NRO.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. NRO.PA Profitability Analysis
1.1 Basic Checks
- In the past year NRO was profitable.
- NRO had a positive operating cash flow in the past year.
- NRO had positive earnings in each of the past 5 years.
- NRO had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 7.06%, NRO is in the better half of the industry, outperforming 76.06% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 13.65%, NRO is in the better half of the industry, outperforming 64.79% of the companies in the same industry.
- The Return On Invested Capital of NRO (11.38%) is better than 74.65% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for NRO is in line with the industry average of 10.82%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.06% | ||
| ROE | 13.65% | ||
| ROIC | 11.38% |
ROA(3y)7.25%
ROA(5y)6.8%
ROE(3y)13.74%
ROE(5y)12.58%
ROIC(3y)12.21%
ROIC(5y)11.57%
1.3 Margins
- NRO has a better Profit Margin (6.09%) than 67.61% of its industry peers.
- NRO's Profit Margin has been stable in the last couple of years.
- NRO has a better Operating Margin (8.90%) than 66.20% of its industry peers.
- In the last couple of years the Operating Margin of NRO has remained more or less at the same level.
- NRO has a Gross Margin of 99.93%. This is amongst the best in the industry. NRO outperforms 95.77% of its industry peers.
- NRO's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.9% | ||
| PM (TTM) | 6.09% | ||
| GM | 99.93% |
OM growth 3Y-3.33%
OM growth 5Y-0.03%
PM growth 3Y-0.09%
PM growth 5Y1.44%
GM growth 3Y0%
GM growth 5Y0%
2. NRO.PA Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NRO is creating some value.
- NRO has about the same amout of shares outstanding than it did 1 year ago.
- The number of shares outstanding for NRO remains at a similar level compared to 5 years ago.
- NRO has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 4.14 indicates that NRO is not in any danger for bankruptcy at the moment.
- The Altman-Z score of NRO (4.14) is better than 85.92% of its industry peers.
- NRO has a debt to FCF ratio of 0.57. This is a very positive value and a sign of high solvency as it would only need 0.57 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 0.57, NRO belongs to the best of the industry, outperforming 88.73% of the companies in the same industry.
- NRO has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
- NRO's Debt to Equity ratio of 0.08 is amongst the best of the industry. NRO outperforms 84.51% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.57 | ||
| Altman-Z | 4.14 |
ROIC/WACC1.46
WACC7.82%
2.3 Liquidity
- A Current Ratio of 2.31 indicates that NRO has no problem at all paying its short term obligations.
- NRO has a better Current ratio (2.31) than 94.37% of its industry peers.
- A Quick Ratio of 2.31 indicates that NRO has no problem at all paying its short term obligations.
- NRO has a better Quick ratio (2.31) than 95.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.31 | ||
| Quick Ratio | 2.31 |
3. NRO.PA Growth Analysis
3.1 Past
- NRO shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.44%.
- The Earnings Per Share has been growing by 11.23% on average over the past years. This is quite good.
- The Revenue has been growing slightly by 7.39% in the past year.
- The Revenue has been growing by 9.70% on average over the past years. This is quite good.
EPS 1Y (TTM)4.44%
EPS 3Y11.55%
EPS 5Y11.23%
EPS Q2Q%-7.43%
Revenue 1Y (TTM)7.39%
Revenue growth 3Y11.8%
Revenue growth 5Y9.7%
Sales Q2Q%5.42%
3.2 Future
- The Earnings Per Share is expected to grow by 8.04% on average over the next years. This is quite good.
- Based on estimates for the next years, NRO will show a small growth in Revenue. The Revenue will grow by 5.57% on average per year.
EPS Next Y4.76%
EPS Next 2Y6.9%
EPS Next 3Y8.74%
EPS Next 5Y8.04%
Revenue Next Year6.99%
Revenue Next 2Y6.24%
Revenue Next 3Y6.18%
Revenue Next 5Y5.57%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. NRO.PA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 16.66, which indicates a correct valuation of NRO.
- Based on the Price/Earnings ratio, NRO is valued a bit cheaper than 60.56% of the companies in the same industry.
- NRO is valuated rather cheaply when we compare the Price/Earnings ratio to 25.50, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 14.29, the valuation of NRO can be described as correct.
- NRO's Price/Forward Earnings is on the same level as the industry average.
- NRO's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.67.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.66 | ||
| Fwd PE | 14.29 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, NRO is valued cheaper than 90.14% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of NRO is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.66 | ||
| EV/EBITDA | 3.59 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NRO does not grow enough to justify the current Price/Earnings ratio.
- NRO has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.5
PEG (5Y)1.48
EPS Next 2Y6.9%
EPS Next 3Y8.74%
5. NRO.PA Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 4.02%, NRO is a good candidate for dividend investing.
- The stock price of NRO dropped by -21.01% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
- Compared to an average industry Dividend Yield of 2.78, NRO pays a bit more dividend than its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.89, NRO pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.02% |
5.2 History
- The dividend of NRO is nicely growing with an annual growth rate of 82.05%!
Dividend Growth(5Y)82.05%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
- NRO pays out 57.47% of its income as dividend. This is a bit on the high side, but may be sustainable.
- The dividend of NRO is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP57.47%
EPS Next 2Y6.9%
EPS Next 3Y8.74%
NRO.PA Fundamentals: All Metrics, Ratios and Statistics
EPA:NRO (3/25/2026, 10:08:48 AM)
34.65
+1 (+2.97%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)03-11 2026-03-11
Earnings (Next)05-06 2026-05-06
Inst Owners12.62%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap843.03M
Revenue(TTM)832.18M
Net Income(TTM)50.68M
Analysts84
Price Target53.04 (53.07%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.02% |
Yearly Dividend1.2
Dividend Growth(5Y)82.05%
DP57.47%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)4.76%
EPS NY rev (3m)4.76%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.66 | ||
| Fwd PE | 14.29 | ||
| P/S | 1.01 | ||
| P/FCF | 11.66 | ||
| P/OCF | 10 | ||
| P/B | 2.27 | ||
| P/tB | 2.73 | ||
| EV/EBITDA | 3.59 |
EPS(TTM)2.08
EY6%
EPS(NY)2.42
Fwd EY7%
FCF(TTM)2.97
FCFY8.58%
OCF(TTM)3.46
OCFY10%
SpS34.2
BVpS15.26
TBVpS12.69
PEG (NY)3.5
PEG (5Y)1.48
Graham Number26.72
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.06% | ||
| ROE | 13.65% | ||
| ROCE | 15.78% | ||
| ROIC | 11.38% | ||
| ROICexc | 28.14% | ||
| ROICexgc | 41.95% | ||
| OM | 8.9% | ||
| PM (TTM) | 6.09% | ||
| GM | 99.93% | ||
| FCFM | 8.69% |
ROA(3y)7.25%
ROA(5y)6.8%
ROE(3y)13.74%
ROE(5y)12.58%
ROIC(3y)12.21%
ROIC(5y)11.57%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.96%
ROCE(5y)16.06%
ROICexgc growth 3YN/A
ROICexgc growth 5Y9.54%
ROICexc growth 3YN/A
ROICexc growth 5Y6.91%
OM growth 3Y-3.33%
OM growth 5Y-0.03%
PM growth 3Y-0.09%
PM growth 5Y1.44%
GM growth 3Y0%
GM growth 5Y0%
F-Score7
Asset Turnover1.16
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.57 | ||
| Debt/EBITDA | 0.32 | ||
| Cap/Depr | 66.65% | ||
| Cap/Sales | 1.44% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 91.59% | ||
| Profit Quality | 142.65% | ||
| Current Ratio | 2.31 | ||
| Quick Ratio | 2.31 | ||
| Altman-Z | 4.14 |
F-Score7
WACC7.82%
ROIC/WACC1.46
Cap/Depr(3y)79.83%
Cap/Depr(5y)65.86%
Cap/Sales(3y)1.84%
Cap/Sales(5y)1.6%
Profit Quality(3y)115.8%
Profit Quality(5y)139.08%
High Growth Momentum
Growth
EPS 1Y (TTM)4.44%
EPS 3Y11.55%
EPS 5Y11.23%
EPS Q2Q%-7.43%
EPS Next Y4.76%
EPS Next 2Y6.9%
EPS Next 3Y8.74%
EPS Next 5Y8.04%
Revenue 1Y (TTM)7.39%
Revenue growth 3Y11.8%
Revenue growth 5Y9.7%
Sales Q2Q%5.42%
Revenue Next Year6.99%
Revenue Next 2Y6.24%
Revenue Next 3Y6.18%
Revenue Next 5Y5.57%
EBIT growth 1Y0.63%
EBIT growth 3Y8.08%
EBIT growth 5Y9.67%
EBIT Next Year22.37%
EBIT Next 3Y14.47%
EBIT Next 5Y11.67%
FCF growth 1Y13.36%
FCF growth 3Y7.7%
FCF growth 5Y6.25%
OCF growth 1Y11.51%
OCF growth 3Y9.37%
OCF growth 5Y6.59%
NEURONES / NRO.PA Fundamental Analysis FAQ
What is the fundamental rating for NRO stock?
ChartMill assigns a fundamental rating of 7 / 10 to NRO.PA.
What is the valuation status for NRO stock?
ChartMill assigns a valuation rating of 4 / 10 to NEURONES (NRO.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for NEURONES?
NEURONES (NRO.PA) has a profitability rating of 7 / 10.
How financially healthy is NEURONES?
The financial health rating of NEURONES (NRO.PA) is 9 / 10.
Can you provide the expected EPS growth for NRO stock?
The Earnings per Share (EPS) of NEURONES (NRO.PA) is expected to grow by 4.76% in the next year.